Stock Markets March 30, 2026

MakeMyTrip Shares Drop After Short Seller Alleges Pricing and Accounting Problems

Morpheus Research report points to alleged price parity enforcement, potential under-provisioning and lingering receivable from insolvent airline; shares fall 3.5%

By Nina Shah MMYT
MakeMyTrip Shares Drop After Short Seller Alleges Pricing and Accounting Problems
MMYT

MakeMyTrip Limited (NASDAQ:MMYT) saw its shares decline 3.5% after a short-seller report from Morpheus Research accused the Indian online travel agency of continuing to enforce price parity with hotel partners, despite a 2022 Competition Commission order, and raised questions about the company’s accounting for fines, receivables and adjusted metrics.

Key Points

  • Morpheus Research alleges MakeMyTrip enforces price parity through a "price competitiveness score" affecting hotel rankings despite a 2022 CCI order; this concerns competition and hospitality sectors.
  • The short-seller questions MakeMyTrip’s provisioning for the October 2022 CCI fine, estimating the unpaid balance with interest could reach $34 million; this raises regulatory and financial reporting issues for the company.
  • Morpheus cites a $20 million receivable from insolvent Go Air with only half provisioned, and a $212 million cumulative difference between adjusted profits and IFRS profits since 2021, highlighting accounting and credit risk exposure that affects investors and credit analysts.

Shares of MakeMyTrip Limited (NASDAQ:MMYT) fell 3.5% on Monday following publication of a report by short-seller Morpheus Research that alleges a range of commercial and accounting shortcomings at the Indian online travel agency.

Allegations on price parity and CCI fine

The report asserts that MakeMyTrip continues to implement price parity measures with its hotel partners despite a 2022 directive from India’s Competition Commission of India (CCI) to cease such conduct. The company was fined approximately $26.1 million in October 2022 for practices regulators described at the time as "anti-competitive" and "abusive" in relation to its hotel offerings.

Morpheus, which disclosed it holds a short position in MMYT, said it interviewed 103 industry experts, a group that included former employees. Based on those interviews, the report claims MakeMyTrip enforces price parity not through explicit contracts but via a "price competitiveness score" that it uses to influence hotel rankings on its platform, effectively penalizing hotels that are not competitively priced on its marketplace.

Accounting and provisioning concerns

On the accounting front, Morpheus questioned whether MakeMyTrip has fully provisioned for the potential liability stemming from the 2022 CCI fine. While the company paid a 10% deposit as part of its appeal, the short-seller estimates that the remaining balance plus accrued interest could total as much as $34 million. The appeal is pending, with the next hearing set for April 29, 2026.

The report also flagged a $20 million receivable from insolvent airline Go Air, noting that MakeMyTrip has provisioned for impairment on only half of that amount.

Additionally, Morpheus highlighted a divergence between MakeMyTrip’s adjusted profitability metrics and IFRS-reported profits, estimating a cumulative difference of $212 million since 2021.

Market position and competition

MakeMyTrip is reported to control roughly 50% of India’s online travel agency market and generates about 43% of its margin from hotel room night sales. The company’s market valuation is cited at $3.5 billion. The short-seller further alleges that MakeMyTrip is losing market share to competitors, including Booking.com and its subsidiary Agoda, based on interviews with hotel and airline executives.

What remains unresolved

The Morpheus report raises multiple questions about MakeMyTrip’s commercial practices, the sufficiency of its accounting reserves, the collectability of certain receivables and the relationship between adjusted and IFRS results. Many of these issues hinge on ongoing legal appeals, the outcome of which is not known at this time.


Disclosure

Risks

  • Ongoing regulatory and legal uncertainty related to the CCI fine and the outcome of the appeal (next hearing April 29, 2026) - impacts the company’s legal provisions and potential cash outflows.
  • Potential under-provisioning for the $20 million receivable from insolvent Go Air could translate into additional impairments if collectability worsens - affects the travel and airline receivables sector.
  • Reliance on adjusted metrics that diverge by $212 million from IFRS profits since 2021 could obscure true earnings quality and complicate investor assessment of profitability - impacts equity investors and financial analysts.

More from Stock Markets

E*Trade in Talks to Lead Retail Distribution of SpaceX IPO, Potentially Squeezing Robinhood and SoFi Mar 30, 2026 Robinhood Shares Slip After Reports ETrade May Lead SpaceX IPO Retail Allocation Mar 30, 2026 U.K. Stocks Climb as Utilities and Auto Names Lead Gains; Index Up 1.66% Mar 30, 2026 U.K. Stocks Climb as Utilities and Auto Parts Drive Gains; UK 100 Up 1.66% Mar 30, 2026 Madrid Stocks Close Higher as IBEX 35 Advances 0.79% Mar 30, 2026